Prof. Hamdy, Nadia M.
nadia_hamdy@pharma.asu.edu.eg
Department of Biochemistry - Pharmacy
Interests: Genetics, epigenetics, Oncology, repurposing, nano-bio-medicine,
Internal ID: rp12009
- 8 Scopus Citations
- 2 PubMed Citations
ORCID
Loading...
2
0
20
0
false
Full Name
Prof. Hamdy, Nadia M.
Affiliation (Department)
Personal Site
Other emails
Scopus Author ID
WOS ID
Biography
Prof. of Clinical Pharmaceutical Biochemistry and Molecular Biology, Faculty of Pharmacy, Ain Shams University
Dept. Head (Feb. 2013-July 2015 & Sept. 2019- Sept. 2023)
GBD Senior Collaborator, Prof. Hamdy is a member in projects funded by NIH/AHA, European PRIMA, Erasmus+, ASRT-Egypt, STDF-Egypt, STDF-Germany, Higher Ministry of Education Egypt, “HME & Scientific Research”, ASU since 2004-till-now. Dr. Nadia has 135+ publications, 2 edited books and 12 book chapters, with Scopus h index 49 and 50 Masters’ and Ph.D. supervised students.
Prof. Hamdy is one of the world 2% influencing Scientists, she earned 2 International BSI 2025 conference by Harvard University, honorary awards, Ain Shams University Appreciation award in Technological Sciences for the year 2024, the ASRT State Award Dr Shawky el Hadad award in cancer for the year 2023, International “Wendy Harvan” Top Honorary Award & Certificate in February 2023, “Paola Sassone-Corsi” Top Award in February 2021, and ASU first “Best Scientific Project Research Topic” 2021 & Honored by WOE 2020 to 2023 yearly.
Dr. Nadia is an Ambassador of the EACR and Bentham Publisher. She is a member of the Biochemical Society & FEBS, IFCC, ISPE Mena Chapter, ESMO, AAAS, and more.
Dr. Hamdy is a fellow of the GBD, MHE Egypt, ASU, ASRT-Egypt.
Prof. Nadia is a member of the editorial board of 9 Scopus (Q1 & Q2) journals and reviewer for hundereds of international and regional grants, awards, and scientific journals.
A scientific simple info writer and poems writer, published 10 poem books in Arabic. The founder of the “Biochemistry-for-All” group جروب "الكيمياء الحيوية للجميع"as well as the “Biochemistry Passion” page صفحة "شغف الكيمياء الحيوية"
Dept. Head (Feb. 2013-July 2015 & Sept. 2019- Sept. 2023)
GBD Senior Collaborator, Prof. Hamdy is a member in projects funded by NIH/AHA, European PRIMA, Erasmus+, ASRT-Egypt, STDF-Egypt, STDF-Germany, Higher Ministry of Education Egypt, “HME & Scientific Research”, ASU since 2004-till-now. Dr. Nadia has 135+ publications, 2 edited books and 12 book chapters, with Scopus h index 49 and 50 Masters’ and Ph.D. supervised students.
Prof. Hamdy is one of the world 2% influencing Scientists, she earned 2 International BSI 2025 conference by Harvard University, honorary awards, Ain Shams University Appreciation award in Technological Sciences for the year 2024, the ASRT State Award Dr Shawky el Hadad award in cancer for the year 2023, International “Wendy Harvan” Top Honorary Award & Certificate in February 2023, “Paola Sassone-Corsi” Top Award in February 2021, and ASU first “Best Scientific Project Research Topic” 2021 & Honored by WOE 2020 to 2023 yearly.
Dr. Nadia is an Ambassador of the EACR and Bentham Publisher. She is a member of the Biochemical Society & FEBS, IFCC, ISPE Mena Chapter, ESMO, AAAS, and more.
Dr. Hamdy is a fellow of the GBD, MHE Egypt, ASU, ASRT-Egypt.
Prof. Nadia is a member of the editorial board of 9 Scopus (Q1 & Q2) journals and reviewer for hundereds of international and regional grants, awards, and scientific journals.
A scientific simple info writer and poems writer, published 10 poem books in Arabic. The founder of the “Biochemistry-for-All” group جروب "الكيمياء الحيوية للجميع"as well as the “Biochemistry Passion” page صفحة "شغف الكيمياء الحيوية"
Type
Subject
- 3 Obesity
- 3 RBP-4
- 2 3P nano-bio-medicine; Autophagy; Biomarker; Blood–brain barrier (BBB); Central nervous system (CNS); Hallmarks of neuropathology; Inflammasome; Multi-omics; Nano-medicine (NM); Nanotechnology; Neurodegeneration; Non-coding RNAs (ncRNA); Patient stratification; Personalized medical service; Post-COVID-19 complications; Post-CoV-2 infection; Predictive diagnosis; Predictive preventive personalized medicine (PPPM / 3P medicine); Prognostic assessment; SARS-CoV2; Targeted prevention
- 2 bioinformatics; immunoinformatics; monkeypox virus; multi-epitope vaccine; reverse vaccinology
- 2 Cancer; Long ncRNA; NNT-AS1; Non-coding RNA; Oncogenes; Tumor suppressor
- 2 circular RNAs (circRNAs); cytotoxic T lymphocytes; hepatocellular carcinoma (HCC); immunotherapy; natural killer cells; tumor microenvironment (TME)
- 2 Colorectal cancer; HMGA2; Hsa-miR-143-3p; In silico analysis; Liquid biopsy; lncRNA CCDC144NL-AS1
- 2 HCC
- 2 IGF-I
- 2 Inflammation
- next >
Date issued
- 94 2000 - 2998
Fulltext
Results 1-20 of 94 (Search time: 0.0 seconds).